Levosimendan does not reduce the mortality of critically ill adult patients with sepsis and septic shock: a meta-analysis

Background: Previous studies on whether or not levosimendan improved the prognosis of patients with sepsis and septic shock have been inconsistent. We aimed to provide an updated analysis of the therapeutic value of levosimendan in adult patients with sepsis and septic shock, in order to provide evidence-based medical evidence for its use.